Chromadex Corp Stock
Chromadex Corp Stock
We can see a decrease in the price for Chromadex Corp. Compared to yesterday it has lost -€0.040 (-1.490%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Chromadex Corp stock is not clear.
As a result the target price of 3 € shows a slightly positive potential of 13.64% compared to the current price of 2.64 € for Chromadex Corp.
For the coming years our community has positive and negative things to say abot the Chromadex Corp stock. Criterium "EBIT Margin" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -1.490% | 2.326% | -12.583% | -67.407% | -52.000% | 89.928% | -60.000% |
| Intellia Therapeutics Inc | 3.380% | 6.796% | 9.344% | 26.060% | 40.917% | -68.318% | -91.386% |
| Cardio3 Biosciences S.A. | 3.430% | 5.240% | 21.106% | -33.425% | 78.519% | -52.930% | -92.827% |
| Arbutus Biopharma Corp. | 7.600% | 9.877% | 14.987% | 44.387% | 10.917% | 135.949% | 78.643% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat